QBiotics is an Australian public unlisted life sciences company. We are in the business of development and commercialisation of pharmaceutical products that have the potential to address major health problems for humans and companion animals (dogs, cats and horses). Our products are new chemical entities which we source from Australia's pristine tropical rainforests.
QBiotics' focus markets are solid tumour cancer and wound healing. While the human pharmaceutical market is a primary target for QBiotics, we recognise the considerable potential in the significant and growing companion animal markets. Thus, unlike many of our competitors, we develop products simultaneously for both of these two major markets.
Click below for a video on EBC-46 and how it works.